Sofosbuvir is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C- methyluridine-5'-triphosphate. The triphosphate serves as a defective substrate for the NS5B protein, which is the viral RNA polymerase, thus acts as an inhibitor of viral RNA synthesis.